Position in BIO
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,286,010
+$681,681 QoQ
Shares Held
4,380
+102.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#154
of 397 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Empowered Funds, LLC holds $93,312,876 across 21 Medical Devices names. BIO ranks #14 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVCR |
NovoCure Ltd
|
1,154,431 | $17,489,629 | |
| 2 | ABT |
Abbott Laboratories
|
166,065 | $15,068,733 | |
| 3 | MDT |
Medtronic plc
|
162,087 | $12,680,060 | |
| 4 | SYK |
Stryker Corp
|
28,726 | $9,044,091 | |
| 5 | AHCO |
AdaptHealth Corp.
|
646,861 | $6,740,291 | |
| 6 | BSX |
Boston Scientific Corp
|
114,625 | $4,892,191 | |
| 7 | QDEL |
QuidelOrtho Corp
|
267,989 | $4,695,167 | |
| 8 | EW |
Edwards Lifesciences Corp
|
43,120 | $3,900,633 |
All Filings in BIO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,286,010 | 4,380 | Shares | Other | 2026-08-17 | |
| 2026-03-31 | $604,329 | 2,168 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $418,622 | 1,493 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $336,882 | 1,396 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $376,786 | 1,547 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $442,831 | 1,348 | Shares | Sole | 2025-01-28 | |
| No filing history on record for this holder in this stock. | ||||||